Nanodiamonds improve arsenic trioxide treatment of liver tumor by inhibiting metastasis in multiple organs
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: Retinoids in leukemia and cellular processes · Autophagy in Disease and Therapy · Extracellular vesicles in disease
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (58)
Show source-provided references
1. Acute promyelocytic leukemia: from highly fatal to highly curable10.1182/blood-2007-07-102798 ↗
2. Arsenic trioxide controls the fate of the PML-RARalpha oncoprotein by directly binding PML10.1126/science.1183424 ↗
3. The 12-year follow-up of survival, chronic adverse effects, and retention of arsenic in patients with acute promyelocytic leukemia10.1182/blood-2016-02-699439 ↗
4. Arsenic trioxide, a therapeutic agent for APL10.1038/sj.onc.1204762 ↗
5. Engineering 2D arsenic‐phosphorus theranostic nanosheets10.1002/adfm.202101660 ↗
6. Metformin potentiates the effect of arsenic trioxide suppressing intrahepatic cholangiocarcinoma: roles of p38 MAPK, ERK3, and mTORC110.1186/s13045-017-0424-0 ↗
7. In the war against solid tumors arsenic trioxide needs partners
8. A review of arsenic trioxide and acute promyelocytic leukemia
9. Arsenic Trioxide Rescues Structural p53 Mutations through a Cryptic Allosteric Site10.1016/j.ccell.2020.11.013 ↗
10. Arsenic and an old place: rescuing p53 mutants in cancer10.1016/j.ccell.2021.01.012 ↗
11. ATO stabilizes structural p53 mutants10.1038/s41568-021-00337-1 ↗
12. Drugging mutant p5310.1126/scisignal.abh0347 ↗
13. Asian multinational phase II study of darinaparsin in patients with relapsed or refractory peripheral T-cell lymphoma10.1182/blood-2021-145512 ↗
14. Nanodiamond autophagy inhibitor allosterically improves the arsenical-based therapy of solid tumors10.1038/s41467-018-06749-2 ↗
15. Targeting autophagy in cancer10.1038/nrc.2017.53 ↗
16. Mechanisms and context underlying the role of autophagy in cancer metastasis10.1080/15548627.2018.1450020 ↗
17. The HGF-MET axis coordinates liver cancer metabolism and autophagy for chemotherapeutic resistance10.1080/15548627.2019.1580105 ↗
18. Cancer metastasis: building a framework10.1016/j.cell.2006.11.001 ↗
19. Stress-inducible gene Atf3 in the noncancer host cells contributes to chemotherapy-exacerbated breast cancer metastasis10.1073/pnas.1700455114 ↗
20. Chemotherapy-enhanced inflammation may lead to the failure of therapy and metastasis10.2147/OTT.S60114 ↗
21. The role of TLR4 in chemotherapy-driven metastasis10.1158/0008-5472.CAN-14-3525 ↗
22. Residual hepatocellular carcinoma after oxaliplatin treatment has increased metastatic potential in a nude mouse model and is attenuated by Songyou Yin10.1186/1471-2407-10-219 ↗
23. Neoadjuvant chemotherapy induces breast cancer metastasis through a TMEM-mediated mechanism10.1126/scitranslmed.aan0026 ↗
24. Accelerated metastasis after short-term treatment with a potent inhibitor of tumor angiogenesis10.1016/j.ccr.2009.01.021 ↗
25. Chemoresistance to paclitaxel induces epithelial-mesenchymal transition and enhances metastatic potential for epithelial ovarian carcinoma cells
26. Paclitaxel therapy promotes breast cancer metastasis in a TLR4-dependent manner10.1158/0008-5472.CAN-14-0067 ↗
27. Induction of autophagic cell death in malignant glioma cells by arsenic trioxide
28. Multifunctional oncolytic nanoparticles deliver self-replicating IL-12 RNA to eliminate established tumors and prime systemic immunity10.1038/s43018-020-0095-6 ↗
29. Eradication of tumor growth by delivering novel photothermal selenium-coated tellurium nanoheterojunctions10.1126/sciadv.aay6825 ↗
30. Ultra-thermostable RNA nanoparticles for solubilizing and high-yield loading of paclitaxel for breast cancer therapy10.1038/s41467-020-14780-5 ↗
31. Engineering nanoparticles to locally activate T cells in the tumor microenvironment10.1126/sciimmunol.aau6584 ↗
32. Immune modulation of liver sinusoidal endothelial cells by melittin nanoparticles suppresses liver metastasis10.1038/s41467-019-08538-x ↗
33. Erythrocyte leveraged chemotherapy (ELeCt): nanoparticle assembly on erythrocyte surface to combat lung metastasis10.1126/sciadv.aax9250 ↗
34. The properties and applications of nanodiamonds10.1038/nnano.2011.209 ↗
35. Nanodiamond therapeutic delivery agents mediate enhanced chemoresistant tumor treatment10.1126/scitranslmed.3001713 ↗
36. Nanodiamonds as intracellular transporters of chemotherapeutic drug10.1016/j.biomaterials.2010.07.058 ↗
37. An oncogenic role of Agrin in regulating focal adhesion integrity in hepatocellular carcinoma10.1038/ncomms7184 ↗
38. Nude mice multi-drug resistance model of orthotopic transplantation of liver neoplasm and Tc-99m MIBI SPECT on p-glycoprotein10.3748/wjg.v11.i22.3335 ↗
39. Autophagy is activated by TGF-beta and potentiates TGF-beta-mediated growth inhibition in human hepatocellular carcinoma cells10.1158/0008-5472.CAN-08-4401 ↗
40. TGFbeta in cancer10.1016/j.cell.2008.07.001 ↗
41. Role of PML SUMOylation in arsenic trioxide-induced fibrosis in HSCs10.1016/j.lfs.2020.117607 ↗
42. Bi-directional regulation of TGF-β/Smad pathway by arsenic: a systemic review and meta-analysis of in vivo and in vitro studies10.1016/j.lfs.2019.01.042 ↗
43. TGF-beta-induced epithelial to mesenchymal transition10.1038/cr.2009.5 ↗
44. The critical role of CD133(+)CD44(+/high) tumor cells in hematogenous metastasis of liver cancers10.1038/cr.2011.139 ↗
45. Cancer cell-autonomous TRAIL-R signaling promotes KRAS-driven cancer progression, invasion, and metastasis10.1016/j.ccell.2015.02.014 ↗
46. Regulation of in situ to invasive breast carcinoma transition10.1016/j.ccr.2008.03.007 ↗
47. Crosstalk between autophagy and epithelial-mesenchymal transition and its application in cancer therapy10.1186/s12943-019-1030-2 ↗
48. Starvation-induced autophagy promotes the invasion and migration of human bladder cancer cells via TGF-β1/Smad3-mediated epithelial-mesenchymal transition activation10.1002/jcb.27788 ↗
49. Methods in mammalian autophagy research10.1016/j.cell.2010.01.028 ↗
50. The histone H4 lysine 16 acetyltransferase hMOF regulates the outcome of autophagy10.1038/nature12313 ↗
51. SUMO1 promotes Aβ production via the modulation of autophagy10.4161/15548627.2014.984283 ↗
52. NR1D1 ameliorates Mycobacterium tuberculosis clearance through regulation of autophagy10.1080/15548627.2015.1091140 ↗
53. LC3, GABARAP and GATE16 localize to autophagosomal membrane depending on form-II formation10.1242/jcs.01131 ↗
54. NUPR1 maintains autolysosomal efflux by activating SNAP25 transcription in cancer cells10.1080/15548627.2017.1338556 ↗
55. Suppression of TG-interacting factor sensitizes arsenic trioxide-induced apoptosis in human hepatocellular carcinoma cells10.1042/BJ20101653 ↗
56. Epithelial-mesenchymal transitions in development and disease10.1016/j.cell.2009.11.007 ↗
57. Mass spectrometry imaging reveals the sub-organ distribution of carbon nanomaterials10.1038/nnano.2014.282 ↗
58. Principles of nanoparticle design for overcoming biological barriers to drug delivery10.1038/nbt.3330 ↗